MUTAGENICITY OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP) WHEN ACTIVATED BY HAMSTER PANCREATIC DUCT EPITHELIAL-CELLS - A CHEMOPREVENTIVE ROLE FOR GLUTATHIONE
T. Lawson et al., MUTAGENICITY OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP) WHEN ACTIVATED BY HAMSTER PANCREATIC DUCT EPITHELIAL-CELLS - A CHEMOPREVENTIVE ROLE FOR GLUTATHIONE, Mutation research, 375(1), 1997, pp. 73-78
We have shown a role for glutathione (GSH) in the detoxification of 2-
amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) using mutagenicit
y in V79 cells as the end-point. Immortalized hamster pancreas duct ep
ithelial cells (CK cells) were used to metabolize PhIP in this assay.
Intracellular GSH concentrations were lowered by treatment with buthio
nine sulfoximine (BSO) and were raised by treatment with sodium sulfit
e. BSO treatment (10 mM, 4 h) reduced the GSH concentration in V79 cel
ls from 18 +/- 1 to 6 +/- 1 nmol/mg protein, 4 h after treatment. The
mutation frequency of PhIP in these V79 cells rose from 15 +/- 2 to 34
+/- 4 mutants/10(6) survivors in BSO-treated V79 cells. In a related
experiment both CK and V79 cells were treated with sulfite. Sulfite tr
eatment (2 mM, 4 h) produced a greater reduction in PhIP mutagenicity
when the V79 cells were treated with sulfite (from 15 +/- 2 to 3 +/- 1
mutants/10(6) survivors) than when the CK cells were treated (from 15
+/- 2 to 7 +/- 2 mutants/10(6) survivors). These data show a relation
ship between intracellular GSH concentration and the mutagenicity of P
hIP.